We are live on
!
Find out more
CCG
Cypress Capital Group Portfolio holdings
AUM
$889M
1-Year Est. Return
27.23%
This Fund
S&P 500
This Quarter
Est. Return
+2.45%
1 Year Est. Return
+27.23%
3 Year Est. Return
+83.89%
5 Year Est. Return
+113.23%
10 Year Est. Return
+324.61%
AUM
$452M
AUM Growth
+$23.6M
(+5.5%)
Cap. Flow
+$16M
Cap. Flow
% of AUM
3.54%
Top 10 Holdings %
Top 10 Hldgs %
23.81%
Holding
215
New
29
Increased
52
Reduced
80
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$2.15M |
| 2 |
iShares MSCI EAFE Min Vol Factor ETF
EFAV
|
+$2.03M |
| 3 |
Intuit
INTU
|
+$1.62M |
| 4 |
DXC Technology
DXC
|
+$1.42M |
| 5 |
S&P Global
SPGI
|
+$1.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.95M |
| 2 |
Ross Stores
ROST
|
+$1.66M |
| 3 |
TJX Companies
TJX
|
+$1.27M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$1.08M |
| 5 |
PBCT
People's United Financial Inc
PBCT
|
+$1.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.09% |
| 2 | Consumer Staples | 12.96% |
| 3 | Technology | 10.84% |
| 4 | Financials | 9.95% |
| 5 | Industrials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.9B
| $14.1M | 3.13% |
268,402
+916
| +0.3% | +$48.2K |
|
2
Lockheed Martin
LMT
$134B
| $13.3M | 2.95% |
47,991
-1,535
| -3% | -$422K |
|
3
Johnson & Johnson
JNJ
$647B
| $12.9M | 2.85% |
97,246
+5,140
| +6% | +$656K |
|
4
AbbVie
ABBV
$462B
| $11M | 2.43% |
151,339
-1,797
| -1% | -$121K |
|
5
Visa
V
$690B
| $10.5M | 2.33% |
112,341
-1,883
| -2% | -$175K |
|
6
Apple
AAPL
$4.95T
| $10.1M | 2.24% |
280,416
+11,992
| +4% | +$443K |
|
7
Altria Group
MO
$122B
| $9.02M | 2% |
121,132
-1,440
| -1% | -$105K |
|
8
Philip Morris
PM
$306B
| $8.98M | 1.99% |
76,452
+519
| +0.7% | +$60.1K |
|
9
Starbucks
SBUX
$120B
| $8.91M | 1.97% |
152,825
-1,269
| -0.8% | -$76.7K |
|
10
AT&T
T
$167B
| $8.72M | 1.93% |
305,955
-15,067
| -5% | -$444K |
|
11
Paychex
PAYX
$41.6B
| $8.03M | 1.78% |
141,034
-5,022
| -3% | -$295K |
|
12
CME Group
CME
$92.6B
| $7.95M | 1.76% |
63,462
-1,234
| -2% | -$148K |
|
|
13
TJX Companies
TJX
$173B
| $7.46M | 1.65% |
206,718
-33,574
| -14% | -$1.27M |
|
14
Eli Lilly
LLY
$1.07T
| $7.27M | 1.61% |
88,311
-1,750
| -2% | -$143K |
|
15
iShares Core US Aggregate Bond ETF
AGG
$138B
| $7.23M | 1.6% |
65,991
-724
| -1% | -$79.1K |
|
16
ExxonMobil
XOM
$642B
| $6.99M | 1.55% |
86,628
+9,221
| +12% | +$754K |
|
17
JPMorgan Chase
JPM
$946B
| $6.97M | 1.54% |
76,215
+14,723
| +24% | +$1.27M |
|
18
iShares Short-Term National Muni Bond ETF
SUB
$11.3B
| $6.9M | 1.53% |
65,240
+1,745
| +3% | +$185K |
|
19
iShares National Muni Bond ETF
MUB
$45.2B
| $6.77M | 1.5% |
61,467
-478
| -0.8% | -$52.6K |
|
20
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.4B
| $6.73M | 1.49% |
55,832
-16
| -0% | -$1.91K |
|
21
Accenture
ACN
$94.4B
| $5.96M | 1.32% |
48,223
-3,520
| -7% | -$429K |
|
22
Illinois Tool Works
ITW
$82.7B
| $5.73M | 1.27% |
39,982
-250
| -0.6% | -$34.9K |
|
|
RAI
23
DELISTED
Reynolds American Inc
RAI
| $5.5M | 1.22% |
84,553
-1,250
| -1% | -$81.6K |
|
24
Microsoft
MSFT
$2.89T
| $5.29M | 1.17% |
76,815
+6,397
| +9% | +$439K |
|
|
CELG
25
DELISTED
Celgene Corp
CELG
| $5.16M | 1.14% |
39,742
+4,450
| +13% | +$545K |
|
Similar funds
KWM
JCM
FCM
BFC
ZI
TOCUITCONY
PCM
SFM
Cypress Capital Group's Q2 2017 Portfolio in Review
As of Q2 2017, Cypress Capital Group held 215 positions worth $452M, up 5.5% from $428M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Cypress Capital Group deployed $16M of net new capital in Q2 2017, opening 29 new positions and adding to 52 existing holdings. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 43,552 shares worth $2.18M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Consumer Staples and Technology.
On the sell side, the largest reduction was Pfizer, an estimated $1.95M trimmed.
- Cypress Capital Group's largest Q2 2017 buy was iShares Core MSCI Emerging Markets ETF: 43,552 shares worth $2.18M.
- Cypress Capital Group added most to Intuit in Q2 2017, an estimated $1.62M increase.
- Cypress Capital Group's biggest Q2 2017 reduction was Pfizer, cutting an estimated $1.95M.
- Cypress Capital Group fully exited NOV in Q2 2017, selling an estimated $567K.
- Cypress Capital Group's ten largest holdings make up 24% of its $452M portfolio in Q2 2017.
- Cypress Capital Group opened 29 new positions and closed 14 in Q2 2017.
- Cypress Capital Group's portfolio value rose 5.5% quarter-over-quarter to $452M.
Based on Cypress Capital Group's 13F filing for Q2 2017, filed 15 Aug 2017.